Literature DB >> 24929209

Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury.

Michelle E Schober1, Daniela F Requena2, Lizeth J Davis2, Ryan R Metzger3, Kimberly S Bennett4, Denise Morita5, Christian Niedzwecki6, Zhihui Yang7, Kevin K W Wang7.   

Abstract

After traumatic brain injury (TBI), proteolysis of Alpha II Spectrin by Calpain 1 produces 145 Spectrin breakdown products (SBDPs) while proteolysis by Caspase 3 produces 120 SBDPs. 145 and 120 SBDP immunoblotting reflects the relative importance of caspase-dependent apoptosis or calpain-dependent excitotoxic/necrotoxic cell death in brain regions over time. In the adult rat, controlled cortical impact (CCI) increased 120 SBDPs in the first hours, lasting a few days, and increased 145 SBDPs within the first few days lasting up to 14 days after injury. Little is known about SBDPs in the immature brain after TBI. Since development affects susceptibility to apoptosis after TBI, we hypothesized that CCI would increase 145 and 120 SBDPs in the immature rat brain relative to SHAM during the first 3 and 5 days, respectively. SBDPs were measured in hippocampi and cortices at post injury days (PID) 1, 2, 3, 5, 7 and 14 after CCI or SHAM surgery in the 17 day old Sprague Dawley rat. 145 SBDPs increased in both brain tissues ipsilateral to injury during the first 3 days, while changes in contralateral tissues were limited to PID2 cortex. 145 SBDPs elevations were more marked and enduring in hippocampus than in cortex. Against expectations, 120 SBDPs only increased in PID1 hippocampus and PID2 cortex. 145 SBDPs elevations occurred early after CCI, similar to previous studies in the adult rat, but resolved more quickly. The minimal changes in 120 SBDPs suggest that calpain-dependent, but not caspase-dependent, cell death predominates in the 17 day old rat after CCI.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell death; Controlled cortical impact; Developmental; Excitotoxicity

Mesh:

Substances:

Year:  2014        PMID: 24929209      PMCID: PMC4131452          DOI: 10.1016/j.brainres.2014.05.046

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  55 in total

Review 1.  Apoptosis after traumatic brain injury.

Authors:  R Raghupathi; D I Graham; T K McIntosh
Journal:  J Neurotrauma       Date:  2000-10       Impact factor: 5.269

2.  A prospective study of short- and long-term neuropsychological outcomes after traumatic brain injury in children.

Authors:  Keith Owen Yeates; H Gerry Taylor; Shari L Wade; Dennis Drotar; Terry Stancin; Nori Minich
Journal:  Neuropsychology       Date:  2002-10       Impact factor: 3.295

3.  Alpha-II-spectrin after controlled cortical impact in the immature rat brain.

Authors:  J Aikman; B O'Steen; X Silver; R Torres; S Boslaugh; S Blackband; K Padgett; K K W Wang; R Hayes; J Pineda
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

4.  10 years outcome from childhood traumatic brain injury.

Authors:  Vicki Anderson; Celia Godfrey; Jeffrey V Rosenfeld; Cathy Catroppa
Journal:  Int J Dev Neurosci       Date:  2011-11-11       Impact factor: 2.457

5.  Long-term attention problems in children with traumatic brain injury.

Authors:  Keith Owen Yeates; Kira Armstrong; Jennifer Janusz; H Gerry Taylor; Shari Wade; Terry Stancin; Dennis Drotar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-06       Impact factor: 8.829

6.  The epidemiology and impact of traumatic brain injury: a brief overview.

Authors:  Jean A Langlois; Wesley Rutland-Brown; Marlena M Wald
Journal:  J Head Trauma Rehabil       Date:  2006 Sep-Oct       Impact factor: 2.710

7.  Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

Authors:  B R Pike; J Flint; S Dutta; E Johnson; K K Wang; R L Hayes
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

Review 8.  Calpain as a therapeutic target in traumatic brain injury.

Authors:  Kathryn E Saatman; Jennifer Creed; Ramesh Raghupathi
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

9.  Diffuse brain injury in the immature rat: evidence for an age-at-injury effect on cognitive function and histopathologic damage.

Authors:  Ramesh Raghupathi; Jimmy W Huh
Journal:  J Neurotrauma       Date:  2007-10       Impact factor: 5.269

10.  Family burden after traumatic brain injury in children.

Authors:  Mary E Aitken; Melissa L McCarthy; Beth S Slomine; Ru Ding; Dennis R Durbin; Kenneth M Jaffe; Charles N Paidas; Andrea M Dorsch; James R Christensen; Ellen J Mackenzie
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  10 in total

1.  Effects of controlled cortical impact and docosahexaenoic acid on rat pup fatty acid profiles.

Authors:  Michelle E Schober; Daniela F Requena; J Alan Maschek; James Cox; Leonardo Parra; Alyssa Lolofie
Journal:  Behav Brain Res       Date:  2019-10-13       Impact factor: 3.332

2.  Rat Model of Brain Injury to Occupants of Vehicles Targeted by Land Mines: Mitigation by Elastomeric Frame Designs.

Authors:  Flaubert Tchantchou; Adam A Puche; Ulrich Leiste; William Fourney; Thomas A Blanpied; Gary Fiskum
Journal:  J Neurotrauma       Date:  2018-01-24       Impact factor: 5.269

3.  Role of α-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury.

Authors:  Shangyu Chen; Qiankun Shi; Shuyun Zheng; Liangshen Luo; Shoutao Yuan; Xiang Wang; Zihao Cheng; Wenhao Zhang
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

4.  Dysfunction of the β2-spectrin-based pathway in human heart failure.

Authors:  Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

Review 5.  Therapeutic strategies to target acute and long-term sequelae of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Neuropharmacology       Date:  2018-06-20       Impact factor: 5.250

Review 6.  The role of βII spectrin in cardiac health and disease.

Authors:  Mohamed H Derbala; Aaron S Guo; Peter J Mohler; Sakima A Smith
Journal:  Life Sci       Date:  2017-11-09       Impact factor: 5.037

7.  Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.

Authors:  Shenandoah Robinson; Jesse L Winer; Justin Berkner; Lindsay A S Chan; Jesse L Denson; Jessie R Maxwell; Yirong Yang; Laurel O Sillerud; Robert C Tasker; William P Meehan; Rebekah Mannix; Lauren L Jantzie
Journal:  J Neurosurg Pediatr       Date:  2016-02-19       Impact factor: 2.375

8.  Blast waves from detonated military explosive reduce GluR1 and synaptophysin levels in hippocampal slice cultures.

Authors:  Marquitta Smith; Thuvan Piehler; Richard Benjamin; Karen L Farizatto; Morgan C Pait; Michael F Almeida; Vladimir V Ghukasyan; Ben A Bahr
Journal:  Exp Neurol       Date:  2016-10-05       Impact factor: 5.330

9.  Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia.

Authors:  Lauren L Jantzie; Jesse L Winer; Christopher J Corbett; Shenandoah Robinson
Journal:  Dev Neurosci       Date:  2015-11-10       Impact factor: 2.984

10.  Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats.

Authors:  Shenandoah Robinson; Jesse L Winer; Lindsay A S Chan; Akosua Y Oppong; Tracylyn R Yellowhair; Jessie R Maxwell; Nicholas Andrews; Yirong Yang; Laurel O Sillerud; William P Meehan; Rebekah Mannix; Jonathan L Brigman; Lauren L Jantzie
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.